National Institute of Biomedical Research, Republic Of The Congo
Context
Co-morbidity
linked to dual HIV-malaria infection is a real public health problem because of
the multiple implications for the health of populations living in countries
with limited resources. However, data-t-on malaria-HIV co-infection are lacking
in the DRC. We will contribute to knowledge on the epidemiology and management
of HIV/malaria co-infection in Kinshasa.Objective
This study aims
to provide a clinical and biological profile of people living with HIV (PLHIV)
followed up for malaria at the Bandalungwa Central Military Hospital (HMCB) in
Kinshasa.Methodology
We conducted a
descriptive retrospective study from 1 January 2017 to 31 December 2018 among
PLHIV hospitalised for malaria at the HMCB. We collected
sociodemographic,clinical and biological data from medical records.The data
were transcribed onto a pre-established collection form, entered into Microsoft
Excel 2016® and analysed using SPSS 21.0 software.®Results
We registered
187 PLHIV, 27.8% (40/187) of whom were co-infected with malaria. The mean age
of subjects with HIV-malaria co-infection was 41.7±12 years, and 57.5% (23/40)
of them were female. The majority of subjects with HIV malaria co-infection
[80% (32/40)] had stage 3 HIV infection (WHO classification), and 85% (34/40)
of the study population had uncomplicated malaria. Fever was the most common
symptom [65% (26/40)] in co-infected patients, followed by headache in 37.5%
(15/40), cough in 20% (8/40) and physical asthenia in 12.5% (5/40).
Biologically, 62.5% (25/40) of subjects with HIV malaria co-infection had a
viral load 10,000
copies/ml and 2.5% (1/40)Conclusion
HIV-malaria
co-infection is present in Kinshasa and manifests itself through a range of
symptoms in the majority of PLHIV. Systematic screening for malaria needs to be
incorporated into the clinical and biological monitoring of PLHIV at various
visits.
Marithe Mukoka Ntumba is a medical doctor, currently a master's student in management of healthcare institutions (ESC CLERMONT), and has been a Research medical doctor at the Rodolphe Merieux INRB-Goma Laboratory for 3 years in the Sampling and Results Reporting, Immuno-Serology and Clinical Research Departments. She has supervised COVID-19 activities during the pandemic in the eastern region of the country (Goma, Beni, Butembo: 2020-2023) and activities related to clinical and biological diagnosis of infectious and non-infectious diseases (2022-2023).